Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Monopar Therapeutics Inc. (MNPR) had Weighted-Average Shares Outstanding (Diluted) of 7.00M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.45M |
|
-- |
|
-- |
|
$3.23M |
|
$-3.23M |
|
$0.78M |
|
$-2.45M |
|
$-2.45M |
|
$-2.45M |
|
$-2.45M |
|
$-2.45M |
|
$-2.45M |
|
$-3.23M |
|
$-3.23M |
|
7.00M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
7.00M |
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$53.75M |
|
-- |
|
$0.12M |
|
$53.87M |
|
$1.58M |
|
-- |
|
$0.08M |
|
$1.66M |
|
$52.20M |
|
$52.20M |
|
$52.20M |
|
6.13M |
|
| Cash Flow Statement Financials | |
$-6.74M |
|
$0.86M |
|
$-0.43M |
|
$45.82M |
|
$39.50M |
|
$-6.31M |
|
$2.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
33.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.70% |
|
-4.70% |
|
-4.55% |
|
-4.70% |
|
$8.52 |
|
$-0.96 |
|
$-0.96 |
|